Author: Daniel Forstein

Littelfuse, Inc. (NASDAQ:LFUS), saw it’s Chairman, President & CEO, Gordon Hunter, lower his stake in the company. Through two transactions, both beginning July 7th and filed July 9th, Hunter disposed of a total of 17,256 shares of common stock. The first move was a sale of 10,000 shares, at an average price of $96.085 per share; while the second transaction saw Hunter decrease his exposure by 7,256 more shares, this time at an average price of $95.26 per share. Following these transactions, Hunter now holds 41,132 shares directly in the corporation. This is not the first time this year that Hunter has altered his position…

Read More

Winnebago Industries, Inc. (NYSE:WGO), saw an insider lower his holdings with the company. Chairman, CEO & President Randy J. Potts disposed of 2,000 shares of common stock at an average price of $26.5 per share. Following the transaction, Potts now directly holds 69,700 shares in the $706.11 million market cap company that is a manufacturer of recreation vehicles (RVs) used primarily in leisure travel and outdoor recreation activities. This is not Potts first move of this type, as he has made both purchases and sales of over 1,000 shares each since February of this year. In addition, there are multiple hedge funds with holdings…

Read More

Monotype Imaging Holdings Inc. (NASDAQ:TYPE), saw an insider decrease his holdings with the company in a transaction filed July 8th. Sr VP, CFO, Treas., and Assistant Secretary Scott E. Landers disposed of 2,000 shares at an average price of $28.7302 per share. Following this transaction, Landers directly holds 64,782 shares in the company. This is not the first move of this type that Landers has made in recent months. Since May of this year, Landers has sold 4,000 additional shares of common stock in Monotype Imaging Holdings Inc. (NASDAQ:TYPE), the $1.12 billion market cap corporation that is a provider of text imaging solutions. The Company’s end user…

Read More

URS Corp (NYSE:URS), saw three insiders increase their exposure in the company. Directors Lydia H. Kennard, Douglas Stotlar, & Joseph W. Ralston all acquired 616 shares of common stock at an average of $50.72 per share. Following these transactions, filed July 8th, Kennard directly holds 18,507 shares; Stotlar directly has 18,372 shares; and Ralston directly owns 22,113 shares in URS Corp (NYSE:URS), the $3.63 billion market cap company that is a provider of engineering, construction and technical services, offering a range of program management, planning, design, engineering, construction and construction management, operations and maintenance, and decommissioning and closure services to public agencies and private sector clients worldwide.…

Read More

Jones Lang LaSalle Inc (NYSE:JLL), saw four insiders alter their holdings with the company. CEO of EMEA Christian Ulbrich bought 2,401 shares at an average of $127.12 per share; President and CEO Colin Dyer gained 3,743 shares at an average price of $127.12 per share; Alastair Hughes, the CEO of Europe, picked up 5,279 shares at an average of $127.12 per share; while the CEO of Investment Management, Jeff A. Jacobson purchased 1,712 shares at an average of $127.12 per share. Following these transactions, Ulbrich now has 21,847 shares directly; Dyer directly holds 74,379 shares; Hughes now has 35,485 shares directly; while Jacobson…

Read More

Alico, Inc. (NASDAQ:ALCO), saw five insiders raise their profile with the company. These insiders all purchased stock at an average price of $37.49 per share through a series of transactions that were filed on July 8th. Director Andrew W. Krusen Jr. bought 750 shares and now holds 2,586 shares directly and 1,000 shares indirectly; Director and shareholder Remy W. Trafelet acquired 750 shares and now has 2,568 shares directly, and 3,725,457 indirectly; Director Adam Compton gained 750 share and now has 4,699 shares directly; Director Gregory R. Eisner bought 800 shares and now directly holds 2,757 shares; while Director Ramon A. Rodriguez gained 850 shares…

Read More

Cantel Medical Corp. (NYSE:CMN), saw an insider lower his position in the company this past week as he dropped his stakes in the company. Sr. V.P., CFO and Treasurer Craig A. Sheldon, disposed of 6,363 shares at an average $36.7868 share. Following this transaction, Sheldon directly holds 72,191 shares in Cantel Medical Corp. (NYSE:CMN), the $1.49 billion, the provider of infection prevention and control products and services in the healthcare market. Cantel operates in seven segments: Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis, Therapeutic Filtration, Specialty Packaging and Chemistries. In addition, major hedge funds hold prominent roles in the company. Diker Management, the hedge fund run by…

Read More

MTS Systems Corporation (NASDAQ:MTSC), saw four insiders lower their holdings in the company. VP and CFO Susan E. Knight dropped 411 shares of common stock at an average price of $69.78 per share; SVP, GC and CCO Steven G. Mahon sold 374 shares at an average of $69.78 per share; Senior VP and Chief HR Officer Kristin Trecker disposed of 188 shares at an average of $69.78 per share; and President and CEO Jeffrey A. Graves lowered his position by 1,076 shares at an average of $69.78 per share. Following these transactions, Knight 19,340 shares directly; Mahon directly holds 3,197.2589 shares; Trecker…

Read More

Sherwin-Williams Company (NYSE:SHW), saw three insiders raise their position with the company. Director Richard J. Kramer purchased 114 shares at an average of $207.07 per share; director Christine A. Poon bought 28 shares at an average of $207.07 per share, while director Thomas G. Kadien gained 57 shares at an average price of $207.7 per share. Following these transactions, Kramer holds 3,029 shares directly and 928 shares indirectly; Poon directly holds 572 shares and 58 shares indirectly; and Kadien has 1,492 shares directly, while holding 7,373 shares indirectly in Sherwin-Williams Company (NYSE:SHW), the $20.42 billion market cap corporation engaged in the development, manufacture, distribution and…

Read More

Tucows Inc. (NASDAQ:TCX), saw an insider gain holdings in the company. Director Allen Karp acquired 9,375 shares of common stock at an average of $2.24 per share through a transaction that started July 3rd and was filed July 7th. After this transaction, Karp directly holds 28,750 shares in the company while indirectly holding 5,000 shares in Tucows Inc. (NASDAQ:TCX), the $147.99 million market cap corporation that focuses on serving the needs of network of resellers by providing services, interfaces, customer service, reseller-oriented technology and design and development processes. Moreover, there are two major hedge funds involved with the company. John H. Lewis’ Osmium Partners…

Read More

Heico Corp (NYSE:HEI.A), saw an insider lower his stakes in the company. Director Samuel L. Higginbottom disposed of 2,000 shares of common stock at an average of $42.5201 per share. The transaction began on July 3rd and was filed today, July 7th. Following the transaction, Higginbottom now directly owns 325 shares in Heico Corp (NYSE:HEI.A), the $3.13 billion market cap company, that through its subsidiaries, is the manufacturer of Federal Aviation Administration (FAA)-approved jet engine and aircraft component replacement parts, other than the original equipment manufacturers (OEMs) and their subcontractors. Also involved in the company are some major hedge funds that showed a change…

Read More

Cellular Biomedicine Group Inc (NASDAQ:CBMG), saw it’s director, David Bolocan, buy 10,000 shares of common stock at an average price of $5 per share. Following the transaction, started on June 26th and filed July 3rd, Bolocan directly holds a total of 10,000 shares in the company that focuses on developing cell therapies for the treatment of certain degenerative diseases. The Company offers developmental stem cell, progenitor cell, and immune cell projects. Moreover, Cellular Biomedicine Group Inc (NASDAQ:CBMG) is developing biomedicine based on tissue-derived progenitor cells, embryonic stem (ES) cells and cancer-specific dendritic cells. It considers these cell types as viable options for cell-based…

Read More